Skip to content

WHWK WHWK Proceeds From Issuance Of Common Stock And Warrants

Proceeds From Issuance Of Common Stock And Warrants at other companies

Canopy Growth Corporation logo
Canopy Growth CorporationCGC
$0-100%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$2.33M+32.9%
Arvinas logo
ArvinasARVN
$0
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$0-100%
Lightbridge logo
LightbridgeLTBR
$45.49M+707%
Energy Fuels logo
Energy FuelsUUUU
$68.05M+1,538%

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept whwk:ProceedsFromIssuanceOfCommonStockAndWarrants.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's proceeds from issuance of common stock and warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's proceeds from issuance of common stock and warrants?
WHWK (WHWK) reported proceeds from issuance of common stock and warrants of $0 in Q1 2026.
How has WHWK's proceeds from issuance of common stock and warrants changed year-over-year?
WHWK's proceeds from issuance of common stock and warrants decreased by 100.0% year-over-year, from $100M to $0.
What does proceeds from issuance of common stock and warrants mean?
This represents the total cash inflows received by the company from the sale of common equity shares and associated warrants to investors. It is a primary indicator of external equity financing activity used to fund operations, research, or strategic initiatives. High levels of this metric indicate successful capital raising but may signal potential dilution for existing shareholders.